To investigate whether rocaglamide enhanced TRAIL-mediated apoptosis in HCC cells in the present study, HepG2 and Huh-7 cells, which are highly chemoresistant to TRAIL (17), were selected. Here, TNFSF10 is linked to hepatocellular carcinoma.